Skip to content

KRAIG BIOCRAFT LABORATORIES, INC.: 10-Q filed 2018-11-13

What KRAIG BIOCRAFT LABORATORIES, INC. reported in its quarterly report filed 2018-11-13 (fiscal Q3 2018): 30 published measures, 80 facts as tagged in accession 0001654954-18-012535.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-13
Fiscal period
fiscal Q3 2018
Accession
0001654954-18-012535 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KRAIG BIOCRAFT LABORATORIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-30180,606USD
At 2017-12-31114,499USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-30-3,968,558USD
At 2017-12-31-3,375,806USD
At 2016-12-31-2,360,813USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-3022,339USD
At 2017-12-3118,150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-206,981USD92
2018-01-01 to 2018-09-30-674,500USD273
2017-01-01 to 2017-12-31-2,333,100USD365
2017-07-01 to 2017-09-30-279,785USD92
2017-01-01 to 2017-09-30-2,034,269USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-169,363USD273
2017-01-01 to 2017-09-30-650,269USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-3011,448USD273
2017-01-01 to 2017-09-3024,170USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-07-01 to 2018-09-30140,761USD92
2018-01-01 to 2018-09-30401,620USD273
2017-07-01 to 2017-09-3027,222USD92
2017-01-01 to 2017-09-3027,222USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-30185,000USD273
2017-01-01 to 2017-09-30450,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-11,448USD273
2017-01-01 to 2017-09-30-24,170USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-30-26,393,579USD
At 2017-12-31-25,719,079USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-07-01 to 2018-09-300USD92
2018-01-01 to 2018-09-300USD273
2017-07-01 to 2017-09-300USD92
2017-01-01 to 2017-09-300USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-3054,133USD
At 2017-12-3162,494USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-147,948USD92
2018-01-01 to 2018-09-30-527,432USD273
2017-07-01 to 2017-09-30-234,420USD92
2017-01-01 to 2017-09-30-1,904,927USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-30122,955USD
At 2017-12-3148,487USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-07-01 to 2018-09-3059,033USD92
2018-01-01 to 2018-09-30166,992USD273
2017-07-01 to 2017-09-3045,365USD92
2017-01-01 to 2017-09-30129,342USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-304,149,164USD
At 2017-12-313,490,305USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-3099,256USD
At 2017-12-3125,872USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-30288,709USD92
2018-01-01 to 2018-09-30929,052USD273
2017-07-01 to 2017-09-30261,642USD92
2017-01-01 to 2017-09-301,932,149USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-07-01 to 2018-09-3020,221USD92
2018-01-01 to 2018-09-3091,242USD273
2017-07-01 to 2017-09-3025,382USD92
2017-01-01 to 2017-09-30190,989USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-30816,883,910shares
At 2017-12-31816,847,910shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-302,039,423USD
At 2017-12-311,958,751USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-09-3076,064USD
At 2017-12-3156,255USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-09-303,121,201USD
At 2017-12-312,666,856USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30123,695USD92
2018-01-01 to 2018-09-30404,643USD273
2017-07-01 to 2017-09-3065,297USD92
2017-01-01 to 2017-09-301,121,808USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-01-01 to 2018-09-3019,809USD273
2017-01-01 to 2017-09-3014,119USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-59,033USD92
2018-01-01 to 2018-09-30-147,068USD273
2017-07-01 to 2017-09-30-45,365USD92
2017-01-01 to 2017-09-30-129,342USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-300USD273
2017-01-01 to 2017-09-300USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-09-300USD273
2017-01-01 to 2017-09-30450,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-3073,384USD273
2017-01-01 to 2017-09-30-4,636USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-3040,514USD273
2017-01-01 to 2017-09-3093,069USD273

Inspect the source

Entity
KRAIG BIOCRAFT LABORATORIES, INC. / CIK 0001413119
Captured
2026-09-20T08:02:08.774Z
SEC response SHA-256
920795b2181369f3ae04be68b2de22ae3d9ee7808a72922b976f9dc124464bc6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001413119.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))